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Erratum
Identifying Targeted Strategies to Improve Smoking Cessation Support for Cancer Patients: Erratum
An error appeared in the degree listed for one of the authors of the article that appeared on page 1532 of the November 2015 issue of the Journal.
The author’s name should have appeared as Shiva Dibaj, MS.
The authors regret this error.
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